SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?


To: Pseudo Biologist who wrote (984)2/9/1999 10:50:00 PM
From: William Strop  Respond to of 1972
 
From the Vical website today (2/9/99)...

Anticipated Events

Initiation of clinical trial for naked DNA HIV vaccine in collaboration with Merck.

So you are right on, Merck has dibs on using the Vical naked dna technology for AIDs vaccine.

I believe I heard that the African vaccine has live virus & Vical technology does not use that... and since Merck has it licensed for AIDs, I doubt that anyone else can use it for AIDs.

Btw, RPR licensed the naked dna technology in Oct/97 for the treatment of Neurodegenerative Diseases.

Check out the web site or Investor relations for a wealth of current & historical information...

Bill